L’Aigle, April 29, 2021– IMV Technologies, leader in assisted reproduction solutions and veterinary imaging, is pleased to announce that it has joined the group of companies in Montagu Private Equity‘s portfolio.
Montagu entered into private negotiations for the acquisition of IMV Technologies in January. “We are delighted and honored to become officially, as of today, a part of IMV’s future,” said Raphaёl Candelier, Director with the Paris team of Montagu. “We have ‘hit the ground running’, and over the last three months have already started working on certain ideas and projects together with management.”
Since 2007, IMV Technologies has grown significantly, through geographical expansion, acquisition, and market growth. Today, IMV Technologies has manufacturing or administrative footprints in 10 countries and a distributor base spanning at least 120. Its global leadership has extended from artificial insemination to assisted reproduction technologies and veterinary ultrasound.
“Joining Montagu is the result of several months of discussions, but decades of hard work. IMV Technologies is a terrific company, made up of hundreds of dedicated professionals. In Montagu we have found a partner that values what we do and that will foster growth and development for a continuously bright and exciting future,” said Alain de Lambilly, Chairman and CEO of IMV Technologies.
“IMV Technologies’ values of innovation, quality, inclusion, human development and sustainability are just part of what we share with Montagu,” continued de Lambilly. “Our customers can be assured that we will continue to challenge the status quo with innovation and continue to responsibly offer leading products and services that allow them to thrive in our complex global environment.”
The terms of the negotiation are not disclosed. IMV Technologies thanks its advisors at Desfilis Avocats and Sycomore Corporate Finance.
About IMV Technologies :
IMV Technologies is the world leader in animal assisted reproduction biotechnologies. Founded in 1963, IMV Technologies, a French company, has subsidiaries and/or manufacturing facilities in Brazil, China, France, India, Italy, the Netherlands, Russia, Scotland, South Africa, and the United States. IMV Technologies operates leading brands in the areas of semen analysis, assisted reproduction, artificial insemination, and veterinary imaging. IMV Technologies’ Life Sciences division, CryoBio System, manufactures and distributes equipment and supplies for human assisted reproduction and biobanking. For more information: www.imv-technologies.com.